We would love to hear your thoughts about our site and services, please take our survey here.
People possibly taking positions before the anticipated Sussex, Surrey and Kent adoption Q1 ...and FDA partners update (expecting early this year so due an update any day now).
Also there seems to be many articles being published online on a regular basis now, about Genedrive and particular MT-RNR1 that there's bound to be an increasing and more sustained interest in the stock.
Powerhouse are not funding it…
“ Powerhouse will not be required to contribute any capital for these projects. Instead, the collaboration will be based on a license fee and royalties model. This arrangement establishes a long-term relationship between Powerhouse and National H2, while also potentially providing a long-term income stream for the Group.”
Yes indeed Basil! You’re referring to ‘specialist commissioning’ …the presentation and a very interest Q&A (that was published later) is still available on the Investor Meet website.
He said he has 100% clarification that it’s going to happen.
Rollout to Surrey, Kent and Sussex is also expected before the end of March and an announcement regarding FDA partners.
The market will be in for a pleasant surprise soon in that case.
I expect they sold a few yesterday and are talking it down hoping to buy back in cheaper. The trouble is it only takes 2 or 3 reasonable size buys and the ASK shoots up 10% or more. It could really shoot up from this point on any sustained buying.
It has nothing to do with Nice. It’s not a flaw that has been found, it is simply that a small batch of tests were stored incorrectly, in environment too hot. The documentation for the tests is extremely thorough and clearly describes the max and min temperature conditions that the test must be stored within to retain integrity, as with all medical devices and tests.
That’s absolute nonsense Roger lol
Yes exactly, it sounds like it almost certainly happened whilst in transport by the way it was described. Hospitals know very well how to store the tests safely as do Genedrive and manufacturers of course and would have been picked up sooner if it had happened whilst with them.
Neonatal Hearing Screening Device Market is Projected to Hit US$ 68.5 Million at a 4.90% CAGR by 2034.
Mentions Genedrive RNR1 and NICE around paragraph 10…
https://www.openpr.com/news/3397965/neonatal-hearing-screening-device-market-is-projected-to-hit-us
It’s going to go ballistic when positive FDA news is announced. They must be almost ready with the FDA partners deal, JC said ‘early this year’ so has to be very soon.
Very likely imo, the pressure on clinics to adopt it will only increase as nobody wants a lawsuit on their hands.
I did wonder also if special commissioning would be something waiting for the new financial year. I think March is looking like it could be a very exciting month.
It changes, after a small flurry of buys the market makers are quick to block the buying for 5 mins or so and then they allow it again. A few more steady buys and this will quickly shoot up from this price point.
Absolutely, it’s done it many times.
Expecting an update on Surrey, Kent and Sussex rollout in the next few weeks and FDA partners. I’m taking the reference of ‘early this year’ to mean q1.
I’d expect some overseas adoption too now since the distributors have been trained up, are demoing to potential customers and have the test documentation translated into local languages.
The Chinese market was briefly mentioned in the article I just posted, published 2 days ago.
Https://bnnbreaking.com/finance-nav/genedrive-plcs-quest-revolutionizing-neonatal-care-and-preventing-antibiotic-related-hearing-loss
“ Imagine a world where the specter of antibiotic-induced hearing loss in infants is no longer a daunting uncertainty but a preventable reality. This is the world Genedrive seeks to create. The company's dedication is mirrored in its rigorous pursuit of excellence and evidence. A recent study investigating the knowledge, attitudes, beliefs, and practices of hearing screening practitioners in Luzhou, China, sheds light on the global relevance of such diagnostic tools.”
“Genedrive's strategic move to apply for funding under the NICE EVA scheme is a calculated endeavor to bridge the gap between innovation and implementation. The endorsement of such a kit by the NHS could serve as a linchpin for widespread adoption, setting a new standard in neonatal care.“
“ In conclusion, Genedrive PLC's quest for NHS funding for its MT-RNR1 ID kits is more than a milestone in the company's journey; it's a potential leap forward for neonatal care in the UK and beyond. As the healthcare landscape continues to evolve, driven by technological advancements and a deepening understanding of genetic predispositions, initiatives like this underscore the importance of innovation in safeguarding the well-being of future generations. With the NHS's full recommendation, Genedrive's MT-RNR1 ID kits could soon become an integral part of a new, more proactive approach to healthcare, where prevention is paramount, and every child is afforded the best start in life.”
Kent, Surrey and Sussex launch should be announced in the next 5 weeks, the shareprice should move dramatically on that news.
Typo, here it is...
"Genedrive are thrilled to announce our new partnership with Babirus, the exclusive distributor for the Genedrive MT-RNR1 ID Kit in the UAE!"
"Genedrive are thrilled to announce our new partnership with Babirus, the exclusive distributor for the Genedrive MT-RNR1 ID Kit in the UAEGenedrive are thrilled to announce our new partnership with Babirus, the exclusive distributor for the Genedrive MT-RNR1 ID Kit in the UAE!"
Yes quite positive and there's been a whole load of improvements to the device in the past 4 years. When you start digging through LinkedIn and on the web you see there's a vast amount of media, praise and publicity around the test... it's clear the team and industry have been working very hard to push it forward.
They’ve recently published the views of nurses involved in the PALOH study. Carried out in 2020 though only just published.
https://lnkd.in/eurjQyme
World Hearing Day 3rd March.